Estée Lauder launches initiative and Estée Lauder stock costs EUR 81.70 versus EUR 81.68
Published on 10/03/2026 at 11:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Estée Lauder launched a breast cancer research initiative with the Breast Cancer Research Foundation on September 23, 2026, according to the The Estée Lauder Companies newsroom. At 11:36 a.m. CEST on October 3, 2026, Estée Lauder stock was at EUR 81.70 in weekend trading at Lang & Schwarz, up plus 0.02 percent versus the EUR 81.68 close at Lang & Schwarz on October 2, 2026.
Weekend trading
The Lang & Schwarz quote showed a bid of EUR 81.46 and an ask of EUR 81.94 at 11:36 a.m. CEST on October 3, 2026. The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Estée Lauder stock.
The last Xetra trading day
The reference close at Lang & Schwarz was EUR 81.68 on October 2, 2026. The current weekend-trading price is EUR 0.02 above that reference level.
Breast cancer research initiative
The initiative is being established through a $15 million grant from The Estée Lauder Companies Charitable Foundation. The program is focused on breast cancer in younger women and is described by the company as a global research initiative, according to the The Estée Lauder Companies newsroom.
Next Xetra session
The next Xetra session is scheduled for October 5, 2026.
